| HOME >> MEDICINE >> TECHNOLOGY |
Event for Congressional Members and Staff Will Focus on Advances in
Research and Treatment of Lung Cancer in Women
SEATTLE, Sept. 14 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX:), along with the Society for Women's Health Research, the Lung Cancer Alliance and others, will support a panel discussion entitled "Lung Cancer: Being Female Matters to Research," on Capitol Hill to discuss advances in the research and treatment of lung cancer in women on Monday, September 17.
CTI has been conducting clinical trials of its investigational drug, XYOTAX(TM), researching how estrogen levels affect a woman's response to treatment for lung cancer. Data collected from recent XYOTAX trials suggests that estrogen levels may alter the effectiveness of cancer treatment, and that women with higher levels of estrogen had a lower rate of survival in cases of lung cancer.
The event will be held in room B-340 of the Rayburn House Office Building from noon to 1:30 p.m. Speakers will include Laurie Fenton Ambrose, President of the Lung Cancer Alliance, Joan H. Schiller, M.D., Chief of Hematology and Oncology at the University of Texas Southwestern Medical Center and Deputy Director of Simmons Comprehensive Cancer Center, and Jill M. Siegfried, Ph.D., Professor and Vice Chair of Pharmacology at the University of Pittsburgh School of Medicine and co-Director of the Lung and Esophageal Cancer Program at the University of Pittsburgh Cancer Institute (UPCI).
Women and Lung Cancer
Lung cancer is the number one cancer killer of women in the United States -- more than breast and ovarian cancers combined. The American Cancer Society estimates that in 2007 there will be approximately 213,490 new cases of lung cancer in the United States -- up 22 percent from 2006. Of those new cases, 98,620 will be among women -- up 20 percent from a year ago. One in 16 women will develop lung cancer in their lifetime.
"Gende
'/>"/>
| SOURCE Cell Therapeutics, Inc. Copyright©2007 PR Newswire. All rights reserved |